Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REBIF Cause Multiple sclerosis relapse? 158 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Multiple sclerosis relapse have been filed in association with REBIF. This represents 9.0% of all adverse event reports for REBIF.

158
Reports of Multiple sclerosis relapse with REBIF
9.0%
of all REBIF reports
3
Deaths
99
Hospitalizations

How Dangerous Is Multiple sclerosis relapse From REBIF?

Of the 158 reports, 3 (1.9%) resulted in death, 99 (62.7%) required hospitalization, and 3 (1.9%) were considered life-threatening.

Is Multiple sclerosis relapse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REBIF. However, 158 reports have been filed with the FAERS database.

What Other Side Effects Does REBIF Cause?

Injection site erythema (137) Influenza like illness (128) Fatigue (123) Injection site pain (105) Headache (96) Injection site bruising (74) Pyrexia (74) Fall (73) Pneumonia (69) Urinary tract infection (69)

What Other Drugs Cause Multiple sclerosis relapse?

DIMETHYL (6,852) FINGOLIMOD (6,728) NATALIZUMAB (6,478) INTERFERON BETA-1A (5,931) TERIFLUNOMIDE (4,745) GLATIRAMER (3,695) DALFAMPRIDINE (3,322) OCRELIZUMAB (2,326) OFATUMUMAB (1,525) INTERFERON BETA-1B (1,229)

Which REBIF Alternatives Have Lower Multiple sclerosis relapse Risk?

REBIF vs REBOXETINE REBIF vs RECLAST REBIF vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E REBIF vs REGADENOSON REBIF vs REGORAFENIB

Related Pages

REBIF Full Profile All Multiple sclerosis relapse Reports All Drugs Causing Multiple sclerosis relapse REBIF Demographics